Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
The run time of average major-release films have ballooned in recent years. And, yes, Marvel movies are partly to blame. By James Hibberd Writer-at-Large You know the feeling: You’re sitting in a ...
Shoulder-length hair can sometimes feel like a bit of an in-between. It’s not long enough to swish dramatically nor short enough to feel like a statement. But with the right cut and finish, it becomes ...
Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...
Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...
Stay up to date with our Politics newsletter, sent weekly. President Trump promised a long speech for his State of the Union address. On Tuesday night, he delivered. Tuesday's address lasted ...
Includes presidential addresses to joint sessions of Congress. State of the Union addresses that were written or not recorded were omitted. Source: The American Presidency Project The New York Times ...
A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...
Human evolution has long been tied to growing brain size, and new research suggests prenatal hormones may have played a surprising role. By studying the relative lengths of index and ring fingers — a ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...
The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...